Adeza Biomedical Corporation

Women's health product maker announces IPO

Published in Lab Business Week, January 23rd, 2005

Adeza Biomedical Corporation (ADZA) announced the pricing of its initial public offering of 3,750,000 shares of its common stock at a price of $16.00 per share.

All of the shares are being offered by Adeza.

Adeza has granted to the underwriters a 30-day option to purchase up to an additional 562,500 shares at the initial public offering price to cover over-allotments, if any.

UBS Securities LLC is acting as the sole book-running manager of the offering. SG Cowen & Co., Thomas Weisel Partners LLC and William Blair & Company are acting as comanagers of the offering.

This article was prepared by Lab Business Week...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week

Source: Lab Business Week (2005-01-23)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry